CCOP - Montana Cancer Consortium
Billings, Montana, United States
Research foundation in Billings, Montana
2132 Broadwater Ave a1, Billings, MT 59102
About CCOP - Montana Cancer Consortium
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
161
National Cancer Institute (NCI)
92
Alliance for Clinical Trials in Oncology
83
Radiation Therapy Oncology Group
51
Gynecologic Oncology Group
22
NSABP Foundation Inc
19
Eastern Cooperative Oncology Group
16
ECOG-ACRIN Cancer Research Group
9
GOG Foundation
3
ETOP IBCSG Partners Foundation
2
Alliance Foundation Trials, LLC.
1
Clinical Trials at CCOP - Montana Cancer Consortium
During the past decade, CCOP - Montana Cancer Consortium conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 192 clinical trials were completed, i.e. on
average, 6400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 38 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
1994-02-01
Completed
200
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
1994-07-01
2018-05-21
Completed
299
SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
1994-06-01
2011-07-01
Completed
52
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
1994-08-01
2009-11-01
Completed
810
Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
1995-07-01
Completed
36
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
1994-07-07
2009-12-21
Completed
482
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
1994-10-01
2018-05-14
Completed
2,028
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
1994-05-01
2013-11-01
Completed
1,084
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCOP - Montana Cancer Consortium" #1 sponsor was "SWOG Cancer Research Network" with 161 trials, followed by "National Cancer Institute (NCI)" with 92 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 83 trials sponsored, "Radiation Therapy Oncology Group" with 51 trials sponsored and "Gynecologic Oncology Group"
with 51 trials sponsored. Other sponsors include 55 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Montana Cancer Consortium"
#1 collaborator was "National Cancer Institute (NCI)" with 369 trials as a collaborator, "Cancer and Leukemia Group B" with 28 trials as a collaborator, "SWOG Cancer Research Network" with 28 trials as a collaborator, "Eastern Cooperative Oncology Group" with 27 trials as a collaborator and "NCIC Clinical Trials Group" with 24 trials as a collaborator. Other collaborators include 81 different institutions and companies that were
collaborators in the rest 38 trials.
Clinical Trials Conditions at CCOP - Montana Cancer Consortium
According to Clinical.Site data, the most researched conditions in "CCOP - Montana Cancer Consortium" are
"Breast Cancer" (66 trials), "Lung Cancer" (44 trials), "Lymphoma" (28 trials), "Prostate Cancer" (26 trials) and "Leukemia" (25 trials). Many other conditions were trialed in "CCOP - Montana Cancer Consortium" in a lesser frequency.
Clinical Trials Intervention Types at CCOP - Montana Cancer Consortium
Most popular intervention types in "CCOP - Montana Cancer Consortium" are "Drug" (400 trials), "Other" (147 trials), "Biological" (138 trials), "Radiation" (107 trials) and "Procedure" (70 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "radiation therapy" (67 trials), "placebo" (41 trials), "paclitaxel" (38 trials) and "cisplatin" (37 trials). Other intervention names were less common.
Clinical Trials Genders at CCOP - Montana Cancer Consortium
The vast majority of trials in "CCOP - Montana Cancer Consortium" are
337 trials for "All" genders, 103 trials for "Female" genders and 29 trials for "Male" genders.
Clinical Trials Status at CCOP - Montana Cancer Consortium
Currently, there are NaN active trials in "CCOP - Montana Cancer Consortium".
undefined are not yet recruiting,
undefined are recruiting,
65 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 340 completed trials in CCOP - Montana Cancer Consortium,
undefined suspended trials,
and 55 terminated clinical trials to date.
Out of the total trials that were conducted in CCOP - Montana Cancer Consortium, 27 "Phase 1"
clinical trials were conducted, 230 "Phase 2" clinical
trials and 205 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 10 trials that are defined as “Not Applicable".